see attachment
Week2DBresponse--.pdf
Infe
ctio
n
Description Presentation
Causes/Risk
Factors
Treatment per
CDC Additional Info
Can
dida
Fungal
infect
Jun 02, 2025
0 views
This is a sample solution our expert wrote for a client with similar requirements.
see attachment
Week2DBresponse--.pdf
Infe
ctio
n
Description Presentation
Causes/Risk
Factors
Treatment per
CDC Additional Info
Can
dida
Fungal
infection
(yeast)
Vulvar
itching, thick
white
discharge
Antibiotics use,
diabetes,
pregnancy, tight
clothes
Fluconazole
150 mg PO
single dose
Not sexually
transmitted
BV
Bacterial
vaginosis
Thin gray
discharge,
fishy odor
Douching,
multiple partners,
new sex partner
Metronidazole
500 mg PO
BID x 7 days
Not an STI, but
related to sexual
activity
Chl
amy
dia
Bacterial STI
Often
asymptomatic,
discharge,
dysuria
Unprotected sex,
<25 yrs, multiple
partners
Doxycycline
100 mg BID x
7 days
Screen all
sexually active
females <25
Gon
orrh
ea
Bacterial STI
Purulent
discharge,
pelvic pain
Same as
chlamydia
Ceftriaxone
500 mg IM +
doxycycline
Often co-infected
with chlamydia
Tric
hom
onas
Protozoan
STI
Frothy
yellow-green
discharge,
odor
Unprotected sex,
multiple partners
Metronidazole
2g PO single
dose
Treat both
partners
Cer
vicit
is
Inflammation
of cervix
often due to
STI
Bleeding,
discharge,
pelvic pain
Chlamydia,
gonorrhea
Treat based on
causative
organism
Can lead to PID
PID
Infection of
upper
reproductive
tract
Pelvic pain,
fever, cervical
motion pain
Untreated STIs
Ceftriaxone +
doxycycline +
metronidazole
Risk for
infertility
HIV
Virus
affecting
immune
system
Fever, fatigue,
weight loss
Needle sharing,
sex, mother-to-
child
Antiretroviral
therapy (ART)
Lifelong
management
Syp
hilis
Bacterial STI
(Treponema
pallidum)
Chancre, rash,
systemic
symptoms
Sexual contact
with infected
person
Penicillin G
benzathine IM
Multiple stages;
test with RPR/
VDRL
Table 2: STI Knowledge Questions
SOAP Note – Tina, 27-year-old Female
Subjective:
Chief Complaint (CC):
“My vagina is burning, and I have painful blisters.”
HPI (OLDCARTS):
Hep
B
Liver
infection due
to HBV
Fatigue,
jaundice,
nausea
Sexual contact,
needle use
Supportive,
antivirals for
chronic cases
Vaccine available
Hep
C
Liver
infection due
to HCV
Often
asymptomatic,
may cause
fatigue
Blood-to-blood
contact, needle
sharing
Direct-acting
antivirals
(DAAs)
No vaccine;
chronic if
untreated
HS
V
Herpes
simplex virus
(type 1 or 2)
Painful
vesicles/
ulcers, fever
Sexual contact
Acyclovir,
Valacyclovir
Recurrent; no
cure, only
symptom
management
Question Answer
Name 10 Risk Factors for
contracting STIs and HIV
Unprotected sex, multiple partners, new partner, age <25,
MSM, history of STIs, drug use, sex work, inconsistent
condom use, partner with STI
Name 5 safer sex practices
Use condoms, limit partners, regular testing, mutual
monogamy, avoid sex under influence
Can HIV be transmitted
through sweat, saliva, and
tears?
No. HIV is not transmitted through sweat, saliva, or tears due
to insufficient viral load
Name 2 types of intercourse at
highest risk for contracting
HIV
Anal sex (receptive), vaginal sex (receptive)
Why are women more
susceptible to HIV in male-to-
female transmission?
Larger mucosal surface area exposed, higher viral load in
semen, potential microtears during sex
• The patient presented with a C/C of vaginal burning and painful blisters that began 3 days
ago. The area of concern is in her left labia minora. The patient describes that blisters as
painful and having a burning sensation with visible fluid-filled vesicles. Friction, urination,
and tight clothing worsen the pain. The patient describes relief with cool compresses, and
loose clothing. The discomfort is constant with intermittent sharp pain. She rates the pain a
6/10.
Medical History:
• no previous medical history
• no known allergies to drugs, food, or environmental factors
• no recent illnesses or hospitalizations
• vaccinations are up to date
Surgical History:
• No prior surgical history
Social History:
• #2 sexual partners in the last 6–12 months
• Use of protection (condoms)
• Tobacco, alcohol, recreational drug use, x2 a month socially
• sexual practices (oral, vaginal, anal)
Medications:
• Currently not on any medication
Allergies:
• NKDA (No Known Drug Allergies)
Objective:
Vital Signs:
• Temp: 98.6°F
• HR: 76 bpm
• BP: 112/70
• RR: 16/min
• SpO₂: 98% RA
Physical Exam:
• Genital Exam: Multiple small grouped vesicles on an erythematous base noted on the left
labia minora, tender to palpation. No foul-smelling discharge. No cervical motion tenderness.
No inguinal lymphadenopathy.
• Other Systems: Normal
Point of Care Testing (POCT):
• HSV PCR swab from lesion: High sensitivity and specificity for HSV-1 and HSV-2 (CDC,
2021)
• HIV rapid test: Recommended for new STI evaluation
• Urine NAAT for gonorrhea and chlamydia: Evaluate for co-infections
• Syphilis RPR and Hepatitis B/C screening: Per CDC recommendations for STI screening
Assessment/Diagnosis:
Presumptive Diagnosis:
• Genital Herpes Simplex Virus (HSV) Infection – ICD-10: A60.9
Rationale:
• Classic presentation of painful, fluid-filled vesicles on erythematous base, localized on labia
minora, recent unprotected sex, no previous known episodes.
Differential Diagnoses:
1. Contact Dermatitis: Less likely—symptoms typically bilateral and not vesicular.
2. Chancroid: Rare in the U.S.; painful ulcers with ragged borders, not grouped vesicles.
3. Syphilis (Primary): Typically a painless chancre; not vesicular.
Plan:
Pharmacologic Treatment (Assuming HSV PCR Positive):
• Acyclovir 400 mg tablet PO TID for 10 days
Patient Education:
• Medication Use: Take all medication as prescribed, even if symptoms improve early.
• Side Effects: May include nausea, headache, dizziness.
• Transmission: Avoid sexual activity until lesions are fully healed. HSV can be transmitted
even when asymptomatic.
• Safe Sex: Use condoms consistently to reduce recurrence transmission risk.
• Partner Notification: Partners should be informed and may need testing.
• Chronic Management: Discuss suppressive therapy if recurrences occur frequently (>6/
year).
Non-Pharmacologic Management:
• Keep area clean and dry.
• Use sitz baths and loose clothing.
• Apply cool compresses to soothe discomfort.
Follow-Up:
• Return to clinic in 1–2 weeks or sooner if symptoms worsen.
• Retesting or management for other STI test results as they return.
Complications of Non-Treatment:
• Increased risk of HIV transmission
• Severe and prolonged outbreaks, especially in immunocompromised patients
• Psychological distress
• Neonatal HSV transmission risk in future pregnancies
Table 2: STI Knowledge Questions
SOAP Note – Tina, 27-year-old Female
Subjective:
Objective:
Assessment/Diagnosis:
Plan:
Pharmacologic Treatment (Assuming HSV PCR Positive):
Patient Education:
Non-Pharmacologic Management:
Follow-Up:
Complications of Non-Treatment:
Need a similar assignment?
Our expert writers can help you with your specific requirements. Get started today.